Nitroimidazole derivatives: Non-randomness sister chromatid exchanges in human peripheral blood lymphocytes

Nitroimidazole derivatives exhibited genotoxic effect in different experimental conditions. This study focuses on an evaluation of possible genomic targets, at a chromosomal level, of two 5-nitroimidazoles (ornidazole and metronidazole) using the in vitro human peripheral blood culture as experiment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Carballo, M.A
Otros Autores: Martinez, R.A, Mudry, M.D
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2009
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 17855caa a22017057a 4500
001 PAPER-8833
003 AR-BaUEN
005 20230518203840.0
008 190411s2009 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-64549104649 
024 7 |2 cas  |a metronidazole, 39322-38-8, 443-48-1; ornidazole, 16773-42-5; Biological Markers; Metronidazole, 443-48-1; Mutagens; Nitroimidazoles; Ornidazole, 16773-42-5 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a JJATD 
100 1 |a Carballo, M.A. 
245 1 0 |a Nitroimidazole derivatives: Non-randomness sister chromatid exchanges in human peripheral blood lymphocytes 
260 |c 2009 
270 1 0 |m Carballo, M. A.; CIGETOX-Citogenética Humana y Genética Toxicológica, Departamento Bioquímica Clínica, Universidad de Buenos Aires, Junin 956 (1113), Ciudad Autónoma de Buenos Aires, Argentina; email: macarballo2003@yahoo.com.ar 
506 |2 openaire  |e Política editorial 
504 |a Avani, G., Rao, M.V., Genotoxic effects in human lymphocytes exposed to arsenic and vitamin A (2007) Toxicol. in Vitro, 21, pp. 626-631 
504 |a Azzalin, C.M., Mucciolo, E., Bertoni, L., Giulotto, E., Fluorescence in situ hybridization with a synthetic (T2AG3)n polynucleotide detects several intrachromosomal telomere-like repeats on human chromosomes (1997) Cytogenet. Cell Genet, 78 (2), pp. 112-115 
504 |a Bakopoulou, A., Mourelatos, D., Tsiftsoglou, A.S., Mioglou, E., Garefis, P., Sister chromatid exchange, chromosomal aberrations and deleys in cell-cycle kinetics in human lymphocytes induced by dental composite resin eluates (2008) Mutat. Res, 649, pp. 79-90 
504 |a Barrios, L., Miro, R., Caballin, M., Fuster, C., Guedea, F., Subias, A., Egozcue, J., Cytogenetic effects of radiotherapy: Breakpoint distribution in induced chromosome aberrations (1989) Cancer Genet. Cytogenet, 41 (1), p. 6170 
504 |a Becker, N., Thorland, E., Denison, S., Phillips, L., Smith, D., Evidence that instability within the FRA3B region extends four megabases (2002) Oncogene, 57, pp. 8713-8722 
504 |a Carballo, M.A., Alvarez, S., Boveris, A., Cellular stress by light and rose bengal in human lymphocytes (1993) Mutat. Res, 288, pp. 215-222 
504 |a Carballo, M.A., Palermo, A., López Nigro, M., Andrioli, N., Vázquez, R., Mudry, M., Mutagenicidad quimica y evaluación de daño potencial mediante Ensayos de Corto Plazo (ECT). (2001) A. Toxicol. Arg, 9 (1), pp. 4-8 
504 |a Carballo, M.A., Palermo, A., Mudry, M., Toxicogenetic evaluation of metronidazole treatment of women infected with Trichomona vaginalis (2004) Ann. Trop. Med. Parasitol, 98 (2), pp. 139-147 
504 |a Corbin, S., Neilly, M., Espinosa 3rd, R., Davis, E., McKeithan, T., Le Beau, M., Identification of unstable sequences within the common fragile site at 3p14.2: Implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors (2002) Cancer Res, 62 (12), pp. 3477-3484 
504 |a Cortada, C.M., López Nigro, M., Carballo, M.A., Cytotoxicity and P glycoprotein in treatment with niotroimidazoles (2006) Theoria, 15 (2), pp. 34-40 
504 |a Dayan, J., Crajer, M.C., Deguingaund, S., Mutagenic activity of 4 active- principle forms of pharmaceutical drugs. Comparative study in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase systems in cultured mammalian cells (1982) Mutat. Res, 102, pp. 1-12 
504 |a De Meo, M., Vanelle, P., Bernardi, E., Laget, M., Maldonado, J., Jentzer, O., Crozet, M.P., Dumenil, G., Evaluation on mutagenic and genotoxic activities of 48 nitroimidazoles and related imidazole derivatives by the Ames test and the SOS chromotest (1992) Environmental and Molecular Mutagenesis, 19, pp. 167-170 
504 |a Dobías, L., Cerna, M., Rossner, P., Sram, R., Genotoxicity and carcinogenicity of metronidazole (1994) Mutat. Res, 317 (3), pp. 177-194 
504 |a Edwards, D.I., Reduction of nitroimidazoles and DNA damage (1986) Biochemcal Pharmacology, 35, pp. 53-58 
504 |a Feng, S., Kong, Z., Wang, X., Peng, P., Zeng, E.Y., Assessing the genotoxicity of imidacloprid and RH-5849 in human peripheral blood lymphocytes in vitro with comet assay and cytogenetic tests (2005) Ecotox. Environ. Safety, 61, pp. 239-246 
504 |a Gaddini, L., Pelliccia, F., Limongi, M., Rocchi, A., Study of the relationships between common fragile sites, chromosome breakages and sister chromatid exchanges (1995) Mutagenesis, 10 (3), pp. 257-260 
504 |a Glover, T., Stein, C., Induction of sister chromatid exchanges at common fragile sites (1987) Am. J. Hum. Genet, 41 (5), pp. 882-890 
504 |a Goldman, P., Koch, R.L., Yeung, T.C., Chrystal, E.J., Beaulieu Jr, B.B., McLafferty, M.A., Sudlow, G., Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity (1986) Biochem. Pharmacol, 35, pp. 43-51 
504 |a Guglielmi, G.E., Vogt, T.F., Tice, R.R., Induction of sister chromatid exchanges and inhibition of cellular proliferation in vitro, I. Caffeine (1982) Environm. Mutagen, 4, pp. 191-200 
504 |a Hartley-Asp, B., Metronidazole exhibits no cytogenetic effect in the MN test or in human lymphocytes in vitro (1979) Mutat. Res, 67, pp. 193-196 
504 |a Hirsch, B., Sister chromatid exchanges are preferentially induced at expressed and nonexpressed common fragile sites (1991) Hum. Genet, 87, pp. 302-306 
504 |a Kiuru, A., Lindholm, C., Auvinen, A., Saloma, S., Localization of radiation- induced chromosomal breakpoints along human chromosome 1 using a combination of G-banding and FISH (2000) Int. J. Radiat. Biol, 76 (5), pp. 667-672 
504 |a Kolomietz, E., Meyn, M., Pandita, A., Squire, J., The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors (2002) Genes Chromosomes Cancer, 35 (2), pp. 97-112 
504 |a LaRusso NF, Tomasz M, Müller M, Lipman R. 1997. Interaction of Metronidazole with nucleic acids in vitro.Mol.Pharmacol 13: 872-882; Latt, S., Allen, J., Bloom, S., Carrano, A., Falke, E., Kram, D., Schneider, E., Wolff, S., Sister-chromatid exchanges: A report of the Gene-Tox Program (1981) Mutat. Res, 87, pp. 17-62 
504 |a Lerda, D., Biaggi Bistoni, M., Peralta, N., Ychari, S., Vazquez, M., Bosio, G., Fumonisins in foods from Cordoba (Argentina), presence and genotoxicity (2005) Food Chem. Toxicol, 43, pp. 690-698 
504 |a Loesche, W.J., Schmidt, E., Smith, B.A., Morrison, E.C., Caffesse, R., Hujoel, P.P., Effects of Metronidazole on periodontal treatment needs (1991) J. Periodontal, 62 (4), pp. 247-257 
504 |a López-Nigro, M., Palermo, A., Mudry, M., Carballo, M.A., Cytogenetic evaluation of two nitroimidazole derivatives (2003) Toxicol. in Vitro, 17, pp. 35-40 
504 |a Ludlum, D.B., Colinas, R.J., Kirk, M.C., Mehta, J.R., Reaction of reduced metronidazole with guanosine to form an unstable adduct (1988) Carcinogenesis, 9, pp. 593-596 
504 |a Madia, F., Gattazzo, C., Wei, M., Fabrizio, P., Burhans, W.C., Weinberger, M., Galbani, A., Longo, V.D., Longevity mutation in SCH9 prevents recombination errors and premature genomic instability in a Werner/Bloom model system (2008) J. Cell Biol, 180 (1), pp. 67-81 
504 |a Martelli, A., Allavena, A., Robbiano, L., Mattioli, F., Brambilla, G., Comparison of sensitivity of human and rat hepatocytes to the genotoxic effects of metronidazole (1990) Pharmacol. Toxicol, 66, pp. 329-334 
504 |a Martindale, W., Plasmatic concentrations of antiparasitic drugs in man (1993) Extra Pharmacopoeia, pp. 516-523. , Reynolds J ed, The Pharmaceutical Press: London; 
504 |a Matula, T., Validity of in vitro testing (1990) Drug Metab. Rev, 22, pp. 777-787 
504 |a Miller, B.M., Adler, I.D., Suspect spindle poison: Analysis of c-mitotic effect in mouse bone marrow cells (1989) Mutagenesis, 4 (3), pp. 208-215 
504 |a Mudry, M., Carballo, M.A., Labal de Vinuesa, M., González Cid, M., Larripa, I., Mutagenic bioassay of certain pharmacological drugs. III. Metronidazole (MTZ) (1994) Mutat. Res, 305, pp. 127-132 
504 |a Mudry, M., Martinez-Flores, I., Palermo, A., Carballo, M.A., Egozcue, J., García- Caldés, M., Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus (2001) Teratogenesis Carcinogen. Mutag, 21, pp. 197-205 
504 |a Neal, S.B., Probst, G.S., Chemically-induced sister chromatid exchange in vivo in bone marrow of chinese hamster. An evaluation of 24 compounds (1983) Mutat. Res, 113, pp. 33-43 
504 |a Ochi, H., Douglas, H., Sandberg, A., Cytogenetic studies in primary gastric cancer (1986) Cancer Genet. Cytogenet, 22 (4), pp. 295-307 
504 |a http//www.nih.ncbi.gov, On line Mendelian Inheritance in Man. 2003. On line sequenced database of the human genome. Johns Hopkins University, MA. Available at; Palermo, A.M., Reynoso, A.S., López Nigro, M., Mudry, M.D., Carballo, M.A., Teratogenic evaluation of metronidazole and ornidazole using Drosophila melanogaster (2004) Birth Defects Res. (Part A): Clin. Mol. Teratol, 70 (4), pp. 157-162 
504 |a Pekarsky, Y., Zanesi, N., Palamarchuk, A., Huebner, K., Croce, C., FHIT: From gene discovery to cancer treatment and prevention (2002) Lancet Oncol, 3 (12), pp. 748-754 
504 |a Perry, P., Evans, H., Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange (1975) Nature, 258, pp. 121-125 
504 |a Perry, P., Wolf, S., New Giemsa method for differential staining of sister chromatids (1974) Nature, 261, pp. 156-158 
504 |a Raether, W., Hanel, H., Nitroheterocyclic drugs with broad spectrum activity (2003) Parasitol. Res, 90, pp. 19-39 
504 |a Re, J.L., De Méo, M.P., Laget, M., Guiraud, H., Castegnaro, M., Vanelle, P., Duménil, G., Evaluation of the genotoxic activity of metronidazole and dimetridazole in human lymphocytes by the comet assay (1997) Mutat. Res, 375, pp. 147-155 
504 |a Rodriguez Ferreiro, G., Cancino Badías, L., López Nigro, M., Palermo, A., Mudry, M., Prieto Gonzalez, E., Carballo, M.A., DNA single strand breaks in peripheral blood lymphocytes induced by three nitroimidazole derivatives (2002) Toxicol. Lett, 171, pp. 215-222 
504 |a Rudd, M.K., Friedman, C., Pargi, S.S., Linardopoulou, E.V., Hsu, L., Trask, B.J., Elevated rates of Sister Chromatid Exchange at chromosome ends (2007) Plos Genet, 3 (2), pp. 319-323 
504 |a Rustia, M., Shubik, P., Experimental induction of hepatomas mammary tumors and others with metronidazole in non inbred Sas: MRC (W1)BR rats (1979) J. Natl Cancer Inst, 63, pp. 863-868 
504 |a Satanimirovic, Z., Stevanovic, J., Jovanovic, S., Andjelkovic, M., Evaluation of genotoxic effects of Apitol (cymiazole hydrochloride) in vitro by measurement of sister chromatid exchange (2005) Mutat. Res, 588, pp. 152-157 
504 |a Schinkel, A.H., Jonker, J.W., Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview (2003) Adv. Drug Deliv. Rev, 55, pp. 3-29 
504 |a Schmid, O., Speit, G., Genotoxic effects induced by formaldehyde in human blood and implications for the interpretation of biomonitoring studies (2007) Mutagenesis, 22 (1), pp. 69-74 
504 |a Schwartz, S., Astermborski, J., Budacz, A., Boughman, J., Wasserman, S., Cohen, M., Repeated measurement of spontaneous and clastogen induced sister chromatid exchange (1990) Mutat. Res, 234, pp. 51-59 
504 |a Sen, S.K., Kan, H., Wang, J., Lee, J., Wang, H., Callinan, P.A., Dyer, M., Batzer, M.A., Human genomic deletions mediated by recombination between Alu elements (2006) Am. J. Hum. Genet, 79, pp. 41-53 
504 |a Shigemitsu, K., Sekido, Y., Usami, N., Mori, S., Sato, M., Horio, Y., Hasegawa, Y., Shimokata, K., Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion (2001) Oncogene, 20 (31), pp. 4249-4257 
504 |a Sutherland, G.R., Richard, G.I., Fragile sites-cytogenetic similarity with molecular diversity (1999) Am. J. Hum. Genet, 64 (2), pp. 354-359 
504 |a Tedeschi, B., Vernole, L., Sanna, M., Nicoletti, B., Population genetics of aphidicolin induced fragile sites (1992) Hum. Genet, 89 (5), pp. 543-547 
504 |a Tossiti, M., Arvelo, F., Analysis of the distribution pattern of sister chromatid exchanges in mitotic chromosomes of human T-lymphocytes (2001) Cytobios, 105 (410), pp. 163-176 
504 |a Tucker, J., Preston, R., Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges and cancer risk assessment (1996) Mutat. Res, 365, pp. 147-159 
504 |a Tucker, J., Auletta, A., Cimino, M., Dearfield, L., Jacobson-Kram, D., Tice, R., Carrano, A., Sister-chromatid exchange: Second report of the Gene-Tox program (1993) Mutat. Res, 297, pp. 101-180 
504 |a Vercauteren, P., Meulepas, E., Vlietinck, R., Cassiman, J., Van den Berghe, H., Non-uniform distribution of sister chromatid exchanges in human lymphocytes (1986) Chromosoma, 93 (3), pp. 197-202 
504 |a Walton, M.I., Workman, P., Nitroimidazole bioreductive metabolism: Quantitation and characterisation of mouse tissue benzimidazole nitro reductase in vivo and in vitro (1987) Biochem. Pharmacol, 36, pp. 883-896 
504 |a Wenger, S., Chemical induction of sister chromatid exchange at fragile sites (1995) Cancer Genet. Cytogenet, 5 (1), pp. 72-74 
520 3 |a Nitroimidazole derivatives exhibited genotoxic effect in different experimental conditions. This study focuses on an evaluation of possible genomic targets, at a chromosomal level, of two 5-nitroimidazoles (ornidazole and metronidazole) using the in vitro human peripheral blood culture as experimental system. We observed that both derivatives showed a decrease in mitotic index (MI) (P < 0.001), an increase in sister chromatid exchanges (SCE) frequency (P < 0.001) and no modifications in cellular proliferation kinetics (CPK). As a null hypothesis we considered the assumption that larger chromosomes should harbor more SCE, which was viewed using a novel sequential G-band (400 band resolution)/SCE technique. The analysis showed highly significant chi square values (P < 0.001), indicating that SCE frequency per chromosome is not proportional to chromosome length. SCE could be considered an instability indicator due to the high correlation between SCEs in certain chromosomal bands and the exposure to nitroimidazole derivatives. Copyright © 2008 John Wiley & Sons, Ltd.  |l eng 
593 |a CIGETOX-Citogenética Humana y Genética Toxicológica, Departamento Bioquímica Clfnica. INFIBIOC, Universi- Dad de Buenos Aires, Junin 956 (1113), Ciudad Autónoma de Buenos Aires, Argentina 
593 |a Dpto de Filosofia e Ciencias Humanas, Universidade Estadual de Santa Cruz, Brazil 
593 |a GIBE-Grupo de Investigación en Biología Evolutiva Depto Ecología, Genética y Evolución, Facultad de Ciencias Exactas y Naturales, Buenos Aires, Argentina 
593 |a CIGETOX-Citogenética Humana y Genética Toxicológica, Departamento Bioquímica Clínica, Universidad de Buenos Aires, Junin 956 (1113), Ciudad Autónoma de Buenos Aires, Argentina 
690 1 0 |a BIOMARKERS 
690 1 0 |a CHROMOSOMAL DAMAGE 
690 1 0 |a GENOMIC INSTABILITY 
690 1 0 |a GENOTOXICITY 
690 1 0 |a NITROIMIDAZOLES 
690 1 0 |a BIOLOGICAL MARKER 
690 1 0 |a METRONIDAZOLE 
690 1 0 |a NITROIMIDAZOLE DERIVATIVE 
690 1 0 |a ORNIDAZOLE 
690 1 0 |a ADULT 
690 1 0 |a ARTICLE 
690 1 0 |a BLOOD CULTURE 
690 1 0 |a CELL PROLIFERATION 
690 1 0 |a CHROMOSOME 
690 1 0 |a CHROMOSOME BAND 
690 1 0 |a CHROMOSOME DAMAGE 
690 1 0 |a CHROMOSOME SIZE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a CYTOTOXICITY 
690 1 0 |a DRUG EXPOSURE 
690 1 0 |a FEMALE 
690 1 0 |a GENOME ANALYSIS 
690 1 0 |a GENOMIC INSTABILITY 
690 1 0 |a GENOTOXICITY 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a HUMAN EXPERIMENT 
690 1 0 |a IN VITRO STUDY 
690 1 0 |a MALE 
690 1 0 |a MITOSIS INDEX 
690 1 0 |a NORMAL HUMAN 
690 1 0 |a PERIPHERAL LYMPHOCYTE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a SISTER CHROMATID EXCHANGE 
690 1 0 |a BIOLOGICAL MARKERS 
690 1 0 |a CELL DIVISION 
690 1 0 |a CELLS, CULTURED 
690 1 0 |a CHROMOSOME BANDING 
690 1 0 |a DOSE-RESPONSE RELATIONSHIP, DRUG 
690 1 0 |a FEMALE 
690 1 0 |a HUMANS 
690 1 0 |a LEUKOCYTES, MONONUCLEAR 
690 1 0 |a MALE 
690 1 0 |a METRONIDAZOLE 
690 1 0 |a MITOTIC INDEX 
690 1 0 |a MUTAGENICITY TESTS 
690 1 0 |a MUTAGENS 
690 1 0 |a NITROIMIDAZOLES 
690 1 0 |a ORNIDAZOLE 
690 1 0 |a SISTER CHROMATID EXCHANGE 
690 1 0 |a YOUNG ADULT 
653 0 0 |a flagyl, Hoffmann La Roche; tiberal, Hoffmann La Roche 
700 1 |a Martinez, R.A. 
700 1 |a Mudry, M.D. 
773 0 |d 2009  |g v. 29  |h pp. 248-254  |k n. 3  |p J. Appl. Toxicol.  |x 0260437X  |t Journal of Applied Toxicology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-64549104649&doi=10.1002%2fjat.1403&partnerID=40&md5=83dfc0b6373d045124f72ff267277c58  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1002/jat.1403  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_0260437X_v29_n3_p248_Carballo  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0260437X_v29_n3_p248_Carballo  |y Registro en la Biblioteca Digital 
961 |a paper_0260437X_v29_n3_p248_Carballo  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 69786